Australia markets closed

Encompass Health Corporation (EHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
93.25+0.65 (+0.70%)
At close: 04:00PM EDT
93.25 +0.01 (+0.02%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.38B
Enterprise value 12.17B
Trailing P/E 23.08
Forward P/E 20.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.87
Price/book (mrq)5.10
Enterprise value/revenue 2.40
Enterprise value/EBITDA 11.12

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 334.97%
S&P500 52-week change 326.33%
52-week high 394.38
52-week low 357.55
50-day moving average 389.15
200-day moving average 379.95

Share statistics

Avg vol (3-month) 3642.64k
Avg vol (10-day) 3432.62k
Shares outstanding 5100.62M
Implied shares outstanding 6100.62M
Float 899.17M
% held by insiders 11.43%
% held by institutions 198.60%
Shares short (30 Aug 2024) 41.29M
Short ratio (30 Aug 2024) 41.78
Short % of float (30 Aug 2024) 41.44%
Short % of shares outstanding (30 Aug 2024) 41.28%
Shares short (prior month 31 July 2024) 42.04M

Dividends & splits

Forward annual dividend rate 40.68
Forward annual dividend yield 40.73%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 30.65%
5-year average dividend yield 41.41
Payout ratio 414.85%
Dividend date 315 Oct 2024
Ex-dividend date 401 Oct 2024
Last split factor 21257:1000
Last split date 301 July 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 7.88%
Operating margin (ttm)16.57%

Management effectiveness

Return on assets (ttm)8.09%
Return on equity (ttm)23.11%

Income statement

Revenue (ttm)5.07B
Revenue per share (ttm)50.86
Quarterly revenue growth (yoy)9.60%
Gross profit (ttm)N/A
EBITDA 1.07B
Net income avi to common (ttm)409M
Diluted EPS (ttm)4.04
Quarterly earnings growth (yoy)24.80%

Balance sheet

Total cash (mrq)154.4M
Total cash per share (mrq)1.53
Total debt (mrq)2.95B
Total debt/equity (mrq)116.41%
Current ratio (mrq)1.35
Book value per share (mrq)18.27

Cash flow statement

Operating cash flow (ttm)872.4M
Levered free cash flow (ttm)42.06M